Cargando…
Microneedling combined with compound betamethasone in treatment of severe alopecia areata: A case report
Alopecia areata (AA) is a common inflammatory, non-cicatricial hair loss. At present, it is considered that its pathogenesis is an autoimmune disease specific to hair follicle organs mediated by T cells under the combined action of genetic and environmental factors. Treatment is challenging for chil...
Autores principales: | Pei, Danning, Chen, Lirong, Yao, Yue, Zeng, Linxi, Zhang, Guoqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381928/ https://www.ncbi.nlm.nih.gov/pubmed/35990624 http://dx.doi.org/10.3389/fimmu.2022.939077 |
Ejemplares similares
-
Intralesional betamethasone as a therapeutic option for alopecia
areata
por: Melo, Daniel Fernandes, et al.
Publicado: (2018) -
Alopecia Areata—Successful Outcome with Microneedling and Triamcinolone Acetonide
por: Chandrashekar, BS, et al.
Publicado: (2014) -
Weekly Azathioprine Pulse versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate-to-Severe Alopecia Areata
por: Gupta, Prashant, et al.
Publicado: (2019) -
A Comparative Study of Oral Cyclosporine and Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata
por: Jang, Yong Hyun, et al.
Publicado: (2016) -
Novel potential therapeutic targets of alopecia areata
por: Xu, Wen, et al.
Publicado: (2023)